More on biotin treatment mimicking graves' disease

New England Journal of Medicine

Volumn 375, Issue 17, 2016, Pages 1698-

  Trambas, Christina M ^a   Sikaris, Ken A ^a   Lu, Zhong X ^a  

^a MELBOURNE PATHOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; STREPTAVIDIN;

GRAVES DISEASE; HUMAN; IMMUNOASSAY; LETTER; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; THYROID FUNCTION TEST; THYROTOXICOSIS;

BIOTIN; GRAVES DISEASE; HUMANS;

EID: 84992690702     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1611875     Document Type: Letter

References (5)

1. Kummer S, Hermsen D, Distelmaier F. Biotin treatment mimicking Graves' disease. N Engl J Med 2016; 375: 704-6.
2. Sedel F, Papeix C, Bellanger A, et al. High doses of biotin in chronic progressive multiple sclerosis: a pilot study. Mult Scler Relat Disord 2015; 4: 159-69.
3. Trambas CM, Sikaris KA, Lu ZX. A caution regarding highdose biotin therapy: misdiagnosis of hyperthyroidism in euthyroid patients. Med J Aust 2016; 205: 192.
4. Barbesino G. Misdiagnosis of Graves' disease with apparent severe hyperthyroidism in a patient taking biotin megadoses. Thyroid 2016; 26: 860-3.
5. Wijeratne NG, Doery JCG, Lu ZX. Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study. Pathology 2012; 44: 674-5.